Safety and Efficacy of Sunitinib for Advanced Non-Clear Cell Renal Cell Carcinoma

Asia-Pacific Journal of Clinical Oncology - United Kingdom
doi 10.1111/ajco.12408
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Phase 2 Trial of Sunitinib in Patients With Advanced Non–clear Cell Renal Cell Carcinoma

European Urology
Urology
2012English

Sunitinib for Advanced Renal Cell Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Sphingosine Kinase 1 Overexpression Contributes to Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

OncoImmunology
OncologyAllergyImmunology
2018English

Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma

Current Oncology
Oncology
2010English

Clear Cell Papillary Renal Cell Carcinoma

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2019English

Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial

Oncologist
Cancer ResearchMedicineOncology
2015English

Molecular Genetics of Clear-Cell Renal Cell Carcinoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Current Treatment Approach to Non-Clear Cell Renal Carcinoma

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2015English

Systemic Therapy for Metastatic Non–Clear-Cell Renal Cell Carcinoma: Recent Progress and Future Directions

Hematology/Oncology Clinics of North America
OncologyHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy